Get started
Author

Şengül Çağlayan

Observed names: Sengul Caglayan, Sengul Cağlayan, Senğul Caglayan, Çağlayan, Şengül, çağlayan, sengul, Ş. Çağlayan, Şengül Çağlayan, Şengül Çaǧlayan
ORCID: 0000-0003-3014-5692
Observed ORCID: 0000-0003-3014-5692
OpenAlex ID: A5032296450
Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study
2021 · Gülçin Otar Yener, Ayşenur Paç Kısaarslan, et al. · Rheumatology International · 65
PDF
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study
2023 · Ayşenur Paç Kısaarslan, Sümeyra Özdemir Çiçek, et al. · Joint Bone Spine · 35
The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center
2021 · Betül Sözeri, Şengül Çağlayan, et al. · Postgraduate Medicine · 28
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
2022 · Şengül Çaǧlayan, Hafize Emine Sönmez, et al. · Frontiers in Pediatrics · 23
PDF
Low disease activity state in juvenile-onset systemic lupus erythematosus
2021 · Kubra Ozturk, Senğul Caglayan, et al. · Lupus · 23
Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases
2022 · Kadir Ulu, Mustafa Çakan, et al. · Expert Opinion on Biological Therapy · 17
Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study
2023 · Ezgi Deniz Batu, Aybüke Günalp, et al. · Rheumatology International · 15
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children
2023 · Ummusen Kaya Akca, Ezgi Deniz Batu, et al. · Rheumatology · 13
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy
2024 · Kadir Ulu, Emil Aliyev, et al. · Rheumatology · 12
PDF
The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort
2023 · Şengül Çağlayan, Gizem Mardinoğlu, et al. · Clinical Rheumatology · 11
The Multifaceted Presentation of the Multisystem Inflammatory Syndrome in Children: Data from a Cluster Analysis
2022 · Hafize Emine Sönmez, Şengül Çağlayan, et al. · Journal of Clinical Medicine · 11
PDF
How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience
2023 · Semanur Ozdel, Hafize Emine Sönmez, et al. · Pediatric Rheumatology · 10
PDF
Differentiating Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Using Blood Composite Scores: Insights into Clinical Outcomes and Predictive Indices
2025 · Kadir Ulu, Şengül Çağlayan, et al. · Pediatric Cardiology · 9
PDF
Not easy-peasy to diagnose: familial Mediterranean fever unaccompanied by fever
2023 · Selen Duygu Arık, Gülşah Kavrul Kayaalp, et al. · European Journal of Pediatrics · 9
PDF
PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever
2023 · Nuray Aktay Ayaz, Fatma Gül Demirkan, et al. · Modern Rheumatology · 9
Clinical course of COVID-19 in children with rheumatic disease under biologic therapy.
2021 · Ferhat Demir, Kadir Ulu, et al. · Clinical and Experimental Rheumatology · 9
Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study
2024 · Betül Sözeri, Nihal Şahin, et al. · Pediatric Rheumatology · 8
PDF
The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study
2023 · Taner Coşkuner, Şengül Çağlayan, et al. · Expert Opinion on Biological Therapy · 8
Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes
2023 · Ayşe Tanatar, Özlem Akgün, et al. · Expert Opinion on Biological Therapy · 8
Experience of anti-IL-1β and anti-IL-18 combined therapy (MAS825) in recurrent and recalcitrant macrophage activation syndrome
2023 · Şengül Çağlayan, Kadir Ulu, et al. · Rheumatology · 7
PDF
Erysipelas-like Erythema: A Pathognomonic Rash in Children with Familial Mediterranean Fever
2023 · Figen Çakmak, Selen Duygu Arık, et al. · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · 6
PDF
Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices
2025 · Deniz Gezgin Yildirim, Emine Yılmaz Orulluoglu, et al. · Pediatric Rheumatology · 5
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience
2023 · Gülşah Kavrul Kayaalp, Şengül Çağlayan, et al. · Pediatric Rheumatology · 5
PDF
Cardiac involvement in multisystem inflammatory syndrome in children: single-centre experience
2022 · Vildan Atasayan, Özge P. Akbay, et al. · Cardiology in the Young · 5
Real-world efficacy, safety, and drug retention of anakinra and canakinumab in paediatric colchicine-resistant familial Mediterranean fever: Insights from a single-centre cohort
2026 · Şengül Çağlayan, Taner Coşkuner, et al. · Modern Rheumatology · 4
Works count: 59
Citation count: 395
H-index: 11
I10-index: 12
Year
Topic
Type